Dec 13
08:30
08:40
09:10
Moderators: Georgoulias V., Loong H.F.
Preclinical models of GIST - a paradigm for kinase-inhibitor research
10:00
10:50
11:10
Moderators: Broto J.M., Kosmidis P.
12:00
Moderators: Papachristou D., Bovee J.
What is new in soft tissue sarcomas since the latest WHO classification?
12:40
Moderators: Kyriazoglou A., Stergioula A., Hohenberger P.
Critical appraisal of clinical trials in sarcoma, what have we learned in our efforts to cure patients
Impact of randomized studies and large series on surgical strategy
14:10
15:00
15:40
16:10
16:30
17:30
18:00
18:50
Moderators: Papachristou D., Boukovinas I.
Clinical characteristics of sarcoma patients in Greece: the first results of the national sarcoma registry
A national strategy for seamless transition of sarcoma pediatric patients to adult care in Greece
Dec 14
08:30
09:00
Moderators: Kontogeorgakos V., Papakonstantinou E.
FOSTER Consortium - a new, paneuropean initiative in the fight against osteosarcoma
Histopathology and molecular pathology of small cell osteosarcoma - distinction from fusion - driven round cell sarcomas and implications for clinical practice
Does radiotherapy have a role in the curative treatment of osteosarcoma?
Are close surgical margins safe in the surgical treatment of osteosarcoma patients?
10:30
11:00
11:30
12:00
Moderators: Kapetanakis G., Boukovinas I.
Working alongside the regulatory agency to help develop new treatments for sarcomas particularly ultra-rare sarcoms
Referal of sarcoma to reference centers for management: nice to have or must have?
Practice changing solutions for rare and ultrarare sarcomas in Europe
13:00
Moderators: Nixon I., Haas R., Tap W., Kontogeorgakos V., Becker A., Agrogiannis G.
14:30
15:20
16:10
Moderators: Boukovinas I.
The role of mutational analysis and the evolution of the therapeutic landscape in GIST”
16:40
17:15
Moderators: Andreou D., Papadakis V.
iEuroEwing - an update on the new treatment optimization trial for Ewing sarcoma
rEECur - lessons learned from the longest running relapse trial on Ewing sarcoma
18:45
Moderators: Machado I., Bovee J.
Novel AI and molecular tools for sarcoma classification and prognostication
19:15
Moderators: Koutoulidis V., Samoladas E.
Multimodality Imaging of Sarcoma for Characterization, Staging and Treatment Monitoring
19:45
Dec 15
09:30
Moderators: Memos N., Papanastasiou I.
All sarcoma patients must be treated from specialized centers? YES
All sarcoma patients must be treated from specialized centers? NO
10:20
Moderators: Lakiotaki E., De Bree E., Constantinidou A.
Gemcitabine Irinotecan: A promising 3rd line therapy for metastatic sarcoma
A case of the systemic treatment approach of an MSI-H Leiomyosarcoma
case of recurrent dedifferentiated liposarcoma of the scrotum
Major redo thoractomy for oligometastatic lung sarcoma combined with IGTA
12:50
13:20
Moderators: Duran - Moreno J., Papachristou D., Kokkali S., Kyriazoglou A., Boukovinas I.
